GlobeNewswire: Acacia Pharma Group plc Contains the last 10 of 167 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T01:41:01ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2022/06/09/2459502/0/en/Scheme-of-arrangement-becoming-effective.html?f=22&fvtc=4&fvtv=46219Scheme of arrangement becoming effective2022-06-09T11:00:00Z<![CDATA[Acacia Pharma Group PLC]]>https://www.globenewswire.com/news-release/2022/06/07/2457505/0/en/Court-Sanction-of-the-Scheme-of-Arrangement.html?f=22&fvtc=4&fvtv=46219Court Sanction of the Scheme of Arrangement2022-06-07T11:00:00Z<![CDATA[Acacia Pharma Group PLC]]>https://www.globenewswire.com/news-release/2022/05/20/2447445/0/en/Acacia-Pharma-Results-of-the-Court-Meeting-and-the-General-Meeting-held-on-19-May-2022.html?f=22&fvtc=4&fvtv=46219Acacia Pharma Results of the Court Meeting and the General Meeting held on 19 May 20222022-05-20T06:00:00Z<![CDATA[Acacia Pharma Group PLC]]>https://www.globenewswire.com/news-release/2022/04/29/2432964/0/en/Publication-of-Annual-Report-and-Financial-Statements-for-the-Year-ended-31-December-2021.html?f=22&fvtc=4&fvtv=46219Publication of Annual Report and Financial Statements for the Year ended 31 December 20212022-04-29T21:02:51Z<![CDATA[This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.]]>https://www.globenewswire.com/news-release/2022/04/27/2429960/0/en/Publication-of-Scheme-Document.html?f=22&fvtc=4&fvtv=46219Publication of Scheme Document2022-04-27T10:00:00Z<![CDATA[Acacia Pharma Group PLC]]>https://www.globenewswire.com/news-release/2022/03/31/2414158/0/en/Acacia-Pharma-Group-plc-Total-Number-of-Voting-Rights-and-Capital.html?f=22&fvtc=4&fvtv=46219Acacia Pharma Group plc - Total Number of Voting Rights and Capital2022-03-31T16:00:00Z<![CDATA[THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION.]]>https://www.globenewswire.com/news-release/2022/03/30/2413094/0/en/Acacia-Pharma-to-Postpone-Publication-of-its-Results-for-the-Full-Year-2021-Scheduled-on-31-March-2022.html?f=22&fvtc=4&fvtv=46219Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 20222022-03-30T16:00:00Z<![CDATA[THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION]]>https://www.globenewswire.com/news-release/2022/03/28/2410619/0/en/Offer-by-Eagle-Pharmaceuticals-Inc.html?f=22&fvtc=4&fvtv=46219Offer by Eagle Pharmaceuticals, Inc.2022-03-28T06:00:00Z<![CDATA[ACACIA PHARMA GROUP PLC]]>https://www.globenewswire.com/news-release/2022/03/23/2408208/0/en/Acacia-Pharma-Announces-Chief-Financial-Officer-Gary-Gemignani-is-to-Leave-the-Company.html?f=22&fvtc=4&fvtv=46219Acacia Pharma Announces Chief Financial Officer Gary Gemignani is to Leave the Company2022-03-23T06:10:34Z<![CDATA[This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.]]>https://www.globenewswire.com/news-release/2022/03/15/2403811/0/en/Issue-of-Shares-to-Employee-Benefit-Trust.html?f=22&fvtc=4&fvtv=46219Issue of Shares to Employee Benefit Trust2022-03-15T17:07:00Z<![CDATA[This announcement contains regulated information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.]]>